Cargando…
Mutation Analysis of Radioresistant Early-Stage Cervical Cancer
Radiotherapy is a definitive treatment for early-stage cervical cancer; however, a subset of this disease recurs locally, necessitating establishment of predictive biomarkers and treatment strategies. To address this issue, we performed gene panel-based sequencing of 18 stage IB cervical cancers tre...
Autores principales: | Oike, Tae, Sekiguchi, Yoshihito, Yoshimoto, Yuya, Oike, Takahiro, Ando, Ken, Gu, Wenchao, Sasaki, Yasushi, Tokino, Takashi, Iwase, Akira, Ohno, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744703/ https://www.ncbi.nlm.nih.gov/pubmed/35008475 http://dx.doi.org/10.3390/ijms23010051 |
Ejemplares similares
-
The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients
por: Oike, Tae, et al.
Publicado: (2021) -
Granulocyte‐colony stimulating factor‐producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review
por: Shiba, Shintaro, et al.
Publicado: (2020) -
Molecular mechanisms underlying radioresistance: data compiled from isogenic cell experiments
por: Oike, Takahiro, et al.
Publicado: (2020) -
High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy
por: Ota, Norichika, et al.
Publicado: (2021) -
Cervical Stump Cancer Treated With Radiotherapy Using Computed Tomography-Guided Brachytherapy
por: Okada, Kohei, et al.
Publicado: (2021)